Literature DB >> 15463806

The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions.

Anne Vankeerberghen1, Harry Cuppens, Jean-Jacques Cassiman.   

Abstract

Cystic fibrosis is a frequent autosomal recessive disorder that is caused by the malfunctioning of a small chloride channel, the cystic fibrosis transmembrane conductance regulator. The protein is found in the apical membrane of epithelial cells lining exocrine glands. Absence of this channel results in imbalance of ion concentrations across the cell membrane. As a result, fluids secreted through these glands become more viscous and, in the end, ducts become plugged and atrophic. Little is known about the pathways that link the malfunctioning of the CFTR protein with the observed clinical phenotype. Moreover, there is no strict correlation between specific CFTR mutations and the CF phenotype. This might be explained by the fact that environmental and additional genetic factors may influence the phenotype. The CFTR protein itself is regulated at the maturational level by chaperones and SNARE proteins and at the functional level by several protein kinases. Moreover, CFTR functions also as a regulator of other ion channels and of intracellular membrane transport processes. In order to be able to function as a protein with pleiotropic actions, CFTR seems to be linked with other proteins and with the cytoskeleton through interaction with PDZ-domain-containing proteins at the apical pole of the cell. Progress in cystic fibrosis research is substantial, but still leaves many questions unanswered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15463806     DOI: 10.1016/s1569-1993(01)00003-0

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  30 in total

1.  COX-2: a link between airway inflammation and disordered chloride secretion in cystic fibrosis?

Authors:  A Clayton; A J Knox
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

2.  Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis.

Authors:  Tommaso Bruni; Matteo Mameli; Gabriella Pravettoni; Giovanni Boniolo
Journal:  Med Health Care Philos       Date:  2012-08

3.  Genotype-phenotype correlation for pulmonary function in cystic fibrosis.

Authors:  J de Gracia; F Mata; A Alvarez; T Casals; S Gatner; M Vendrell; D de la Rosa; L Guarner; E Hermosilla
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

4.  A SAXS-based ensemble model of the native and phosphorylated regulatory domain of the CFTR.

Authors:  Carlotta Marasini; Lauretta Galeno; Oscar Moran
Journal:  Cell Mol Life Sci       Date:  2012-10-04       Impact factor: 9.261

5.  The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.

Authors:  Sladjana Skopelja; B JoNell Hamilton; Jonathan D Jones; Mei-Ling Yang; Mark Mamula; Alix Ashare; Alex H Gifford; William Fc Rigby
Journal:  JCI Insight       Date:  2016-10-20

Review 6.  Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.

Authors:  Misak Harutyunyan; Yunjie Huang; Kyu-Shik Mun; Fanmuyi Yang; Kavisha Arora; Anjaparavanda P Naren
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-14       Impact factor: 5.464

7.  The glycine residues G551 and G1349 within the ATP-binding cassette signature motifs play critical roles in the activation and inhibition of cystic fibrosis transmembrane conductance regulator channels by phloxine B.

Authors:  Patricia Melin; Caroline Norez; Isabelle Callebaut; Frédéric Becq
Journal:  J Membr Biol       Date:  2006-04-07       Impact factor: 1.843

8.  Increased elongase 6 and Δ9-desaturase activity are associated with n-7 and n-9 fatty acid changes in cystic fibrosis.

Authors:  Kelly F Thomsen; Michael Laposata; Sarah W Njoroge; Obi C Umunakwe; Waddah Katrangi; Adam C Seegmiller
Journal:  Lipids       Date:  2011-05-05       Impact factor: 1.880

9.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

10.  The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis.

Authors:  Frauke Stanke; Tim Becker; Harry Cuppens; Vinod Kumar; Jean-Jacques Cassiman; Silke Jansen; Dragica Radojkovic; Benny Siebert; Jennifer Yarden; David W Ussery; Thomas F Wienker; Burkhard Tümmler
Journal:  Hum Genet       Date:  2006-02-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.